Abnormal expression of eukaryotic translation factors in malignant transformed human bronchial epithelial cells induced by crystalline nickel sulfide

Biomedical and Environmental Sciences

Volumn 19, Issue 1, 2006, Pages 53-60

  Lei, Yi Xiong ^a   Chen, Xue Min ^a   Wu, Gen Rong ^b   Chen, Jia Kun ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Fluorescent quantitative pcr; Human cells; Nickel compounds; Transformation; Translation factors

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; ELONGATION FACTOR 1; INITIATION FACTOR 3; NICKEL; NICKEL SULFIDE;

ARTICLE; BRONCHUS; CELL LINE; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

BIOLOGICAL MARKERS; BRONCHI; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA, COMPLEMENTARY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NICKEL; PEPTIDE ELONGATION FACTOR 1; PROKARYOTIC INITIATION FACTOR-3;

EUKARYOTA;

EID: 33646001441     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Veien N K (1994). Nickel sensitivity and occupational skin disease. Occup Med 9, 81-95.
2. Jarup L (2003). Hazards of heavy metal contamination. Br Med Bull 68, 167-182.
3. Sorahan T, ESMEN N A (2004). Lung cancer mortality in UK nickel-cadmium battery workers, 1947-2000. Occup Environ Med 61, 108-116.
4. Shen H M, Zhang Q F (1994). Risk assessment of nickel carcinogenicity and occupa- tional lung cancer. Environ Health Perspect 102 (Suppl 1), 275-282.
5. 125I-postlabeffing assay. Mutat Res 329, 197-203.
6. IARC (1990). Nickel and nickel compounds, In Chromium, nickel and welding. International Agency for Research on Cancer. 49, 257-445. Lyon, France.
7. Boffetta P (1993). Carcinogenicity of trace elements with reference to evaluations made by the International Agency for Research on Cancer. Scond. J Work Environ Health 19 (Suppl. 1), 67-70.
8. Hartwing A (1998). Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol Lett 102-103, 235-239.
9. Joseph P, Lei Y X, Whong W Z, et al. (2002). Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res 63, 703-707.
10. Joseph P, Lei Y X, Whong W Z, et al. (2002). Oncogenic potential of mouse translation elongation factor-1δ, a novel cadmium-responsive proto-oncogene. J Biol Chem 277, 6131-6136.
11. Lei Y X, Chen J K, Wu Z L (2002). Blocking the translation elongation factor-1δ with its antisense mRNA results in a significant reversal of its oncogenic potential. Teratog Carcinog Mutagen 22, 377-383.
12. Lei Y X, Joseph P, Ong T (2002). Antisense inhibition of translation initiation factor 3 reverses its oncogenic potential. Teratog Carcinog Mutagen 22, 403-409.
13. Ji W D, Wu Z L, Chen J K (2002). Maligannt transformation of human bronchial epithelial cell line induced by crystalline nickel sulfide. Carcinog Teratog Mutagen 14(1), 15-18.
14. Dunkel V C, Rogers C, Swierenga S H, et al. (1991). Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: III. Cell transformation in C3H/10T1/2 mouse embryo cell, BALB/C-3T3 mouse fibroblast and Syrian hamster embryo cell cultures. Mutat Res 246, 285-300.
15. Liyak K J, Flood S J, Marmaro J et al. (1995). Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4(6), 357-362.
16. Gelmini S, Orlando C, Sestini R, et al. (1997). Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. Clin Chem 43(5), 752-758.
17. Vogelstein B, Kinzler R W (1993). The mulistep nature of cancer. Trends Genet 9, 138-141.
18. Zimmer S G, Debenedetti A, Graff J R (2000). Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor promotion, growth, invasion and metastasis. Anticancer Res 20, 1343-1352.
19. Riis B, Rattan S I S, Clark B F C, et al. (1990). Eukaryotic translation elongation factiors. TIBS 15, 420-424.
20. Sonenbeerg N (1993). Translation factors as effectors of cee growth and tumorigenesis. Curr Opin Cell Biol 5, 955-960.
21. Block K L, Vornlocher H P, Hershey J W (1998). Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3. J Biol Chem 273(48), 31901-31908.
22. Nupponen N N, Porkka K, Kakkola L, et al. (1999). Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol 154(6), 1777-1783.
23. Rothe M, Ko Y, Albers P, et al. (2000). Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am J Pathol 157(5), 1597-1604.
24. Mayeur G L, Hershey J W (2002). Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett 514(1), 49-54.
25. Tatsuka M, Mitsui M, Wada A, et al. (1992). Elongation factor-1 alpha gene determines susceptibility to transformation Nature 359, 333-336.
26. Grant A G, Flomen R M, Tizard M L V, et al. (1992). Differential screening of human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1 alpha in tumor cells. Int J Cancer 51, 740-745.
27. Chi K, Jones D V, Frazier M L (1992). Expression of an elongation factor 1 gamma-related equence in adenocarcinomas of the colon. Gastroenterology 103, 98-102.
28. Lew Y, Jones D V, Mars W M, et al. (1992). Expression of longation factor-1 gamma-related sequence in human pancreatic cancer. Pancreas 7, 144-152.
29. Ender B, Lynch P, Kim Y H, et al. (1993). Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenoma. Mol Carcinogenesis 7, 18-20.
30. Su Z, Goldstein N I, Fisher P B (1998). Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci UAS 95, 1764-1769.
31. Shen R, Su Z Z, Olsson C A, et al. (1995). Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci UAS 92, 6778-6782.
32. Joseph P, Lei Y X, Ong T (2004). Up-regulation of expression of translation factors - a novel molecular mechanism for cadmium carcinogenesis. Mol Cell Biochem 255(1-2), 93-101.